8-K
Current Report
Viridian Therapeutics, Inc.\DE Filed Acc 0001193125-17-220120
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading d390233d8k.htm…